Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in Caucasian women

Molecular Diagnosis and Therapy

Volumn 17, Issue 4, 2013, Pages 239-245

  Roszak, Andrzej ^a,b   Lianeri, Margarita ^b   Sowińska, Anna ^b   Jagodziński, Paweł P ^b  

^a Greater Poland Cancer Centre Poznan   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; SMOKING; UTERINE CERVIX CANCER;

EID: 84880788171     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/s40291-013-0036-5     Document Type: Article

References (50)

1. Georgieva S, Iordanov V, Sergieva S. Nature of cervical cancer and other HPV-associated cancers. J BUON. 2009;14(3):391-8.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9. (Pubitemid 29406813)
3. Münger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res. 2002;89(2):213-28. (Pubitemid 35351540)
4. Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. J Infect Chemother. 2012;18(6):807-15.
5. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res. 2002;62(23):7075-82. (Pubitemid 35424103)
6. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361(15):1475-14853.
7. Kim YJ, Wilson DM 3rd. Overview of base excision repair biochemistry. Curr Mol Pharmacol. 2012;5(1):3-13.
8. Fortini P, Pascucci B, Parlatini E, et al. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie. 2003;85(11):1053-71. (Pubitemid 38142361)
9. Masson M, Niedergang C, Schreiber V, et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18(6):3563-71. (Pubitemid 28240528)
10. El-Khamisy SF, Masutani M, Suzuki H, et al. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 2003;31:5526-33. (Pubitemid 37441922)
11. Schreiber V, Dantzer F, Ame JC, et al. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006;7(7):517-28. (Pubitemid 44036457)
12. Kim MY, Zhang T, Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes Dev. 2005;19(17):1951-67. (Pubitemid 41247953)
13. Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment. Cancer Res. 1998;58:5075-8. (Pubitemid 28521164)
14. Heinen CD, Schmutte C, Fishel R. DNA repair and tumorigenesis: lessons from hereditary cancer syndromes. Cancer Biol Ther. 2002;1(5):477-85.
15. Ford BN, Ruttan CC, Kyle VL, et al. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis. 2000;21(11):1977-81.
16. Yu H, Ma H, Yin M, et al. Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis. Genet Epidemiol. 2012;36(1):56-65.
17. Pabalan N, Francisco-Pabalan O, Jarjanazi H, et al. Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis. Mol Biol Rep. 2012;39(12):11061-72.
18. Ye F, Cheng Q, Hu Y, et al. PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma. PLoS One. 2012;7(5):e37446.
19. Leonetti C, Biroccio A, Graziani G, et al. Targeted therapy for brain tumours: role of PARP inhibitors. Curr Cancer Drug Targets. 2012;12(3):218-36.
20. Ranjit GB, Cheng MF, Mackay W, et al. Poly(adenosine diphosphoribose) polymerase in peripheral blood leukocytes from normal donors and patients with malignancies. Clin Cancer Res. 1995;1(2):223-34.
21. Muiras ML, Müller M, Schächter F, et al. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians. J Mol Med. 1998;76:346-54. (Pubitemid 28168333)
22. Lockett KL, Hall MC, Xu J, et al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 2004;64(17):6344-8. (Pubitemid 39129440)
23. Pero RW, Roush GC, Markowitz MM, et al. Oxidative stress, DNA repair, and cancer susceptibility. Cancer Detect Prev. 1990;14(5):555-61.
24. Rajaee-Behbahani N, Schmezer P, Ramroth H, et al. Reduced poly(ADP-ribosyl)ation in lymphocytes of laryngeal cancer patients: results of a case-control study. Int J Cancer. 2002;98(5):780-4. (Pubitemid 34225632)
25. Goncalves A, Finetti P, Sabatier R, et al. Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis. Breast Cancer Res Treat. 2010;127(1):273-81.
26. Nosho K, Yamamoto H, Mikami M, et al. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer. 2006;42(14):2374-81. (Pubitemid 44307612)
27. Staibano S, Pepe S, Lo Muzio L, et al. Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. Hum Pathol. 2005;36(7):724-31. (Pubitemid 41112026)
28. d'Adda di Fagagna F, Hande MP, et al. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat Genet. 1999;23(1):76-80. (Pubitemid 29418792)
29. Nozaki T, Fujihara H, Watanabe M, et al. Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane. Cancer Sci. 2003;94(6):497-500. (Pubitemid 36849712)
30. Tsutsumi M, Masutani M, Nozaki T, et al. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis. 2001;22(1):1-3. (Pubitemid 32098137)
31. Liu Y, Scheurer ME, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev. 2009;18(1):204-14.
32. Rajaraman P, Hutchinson A, Wichner S, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12(1):37-48.
33. Smith TR, Levine EA, Freimanis RI, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis. 2008;29(11):2132-8.
34. Huang M, Dinney CP, Lin X, et al. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2007;16(1):84-91. (Pubitemid 46174268)
35. Li C, Hu Z, Lu J, et al. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007;110(4):867-75. (Pubitemid 47257666)
36. Zhang Q, Li Y, Li X, et al. PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep. 2009;36(6):1461-7.
37. Stern MC, Butler LM, Corral R, et al. Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study. J Nutrigenet Nutrigenomics. 2009;2(6):273-9.
38. Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004;64(12):4378-84. (Pubitemid 38802447)
39. Chiang FY, Wu CW, Hsiao PJ, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008;14(18):5919-24.
40. Zhang Y, Newcomb PA, Egan KM, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(2):353-8. (Pubitemid 43342187)
41. Stern MC, Conti DV, Siegmund KD, et al. DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2363-72. (Pubitemid 351196369)
42. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78(3):464-79. (Pubitemid 43291228)
43. Choi JE, Park SH, Jeon HS, et al. No association between haplotypes of three variants (codon 81, 284, and 762) in poly(ADP-ribose) polymerase gene and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(9):947-9. (Pubitemid 37151535)
44. Cottet F, Blanche H, Verasdonck P, et al. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADPribosyl)ation capacity. J Mol Med. 2000;78(8):431-40.
45. Karlberg T, Thorsell AG, Kallas Å, et al. Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain. J Biol Chem. 2012;287(29):24077-81.
46. Wang XG, Wang ZQ, Tong WM, et al. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun. 2007;354(1):122-6.
47. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;31:20-8.
48. Magnusson PK, Lichtenstein P, Gyllensten UB. Heritability of cervical tumours. Int J Cancer. 2000;88:698-701.
49. Moreno V, Bosch FX, Muñoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002;359:1085-92. (Pubitemid 34270731)
50. Figueroa JD, Malats N, Real FX, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet. 2007;121(2):233-42. (Pubitemid 46404457)